Mosaic ImmunoEngineering Inc.
Mosaic ImmunoEngineering Inc.
Your view on CPMV
Overview
What the company does, where it operates, and who runs it.
About Mosaic ImmunoEngineering Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Steven W. King
- Headquarters
- 1537 South Novato Boulevard, Huntington Beach, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Steven W. King
- Headquarters
- 1537 South Novato Boulevard, Huntington Beach, CA, US
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.